NEW YORK (GenomeWeb News) – Oxford Nanopore Technologies plans to launch an early-access program for its MinIon sequencer in late November, the company said today.

Under the MinIon Access Program, an undisclosed but "substantial" number of selected participants will receive a MinIon system – consisting of the sequencing USB device, flow cells, and software – for a refundable deposit of $1,000 and shipping costs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.